INDUSTRIES SERVED
Pharmaceuticals
When Foreign Particles Threaten Product Safety, the Answers Have to Be Definitive
A visible particle in an injectable. An unidentified contaminant in a finished batch. An FDA observation that demands root cause — not speculation. In pharmaceutical manufacturing, particulate contamination isn't just a quality issue; it's a patient safety issue, a regulatory issue, and a production issue, often all at once.
That's the moment most clients reach out to us. They need answers that are specific, defensible, and fast enough to keep a product line moving.
From Identification to Resolution
RJ Lee Group's Pharmaceutical Services Department operates as a cGMP-compliant, ISO 17025-certified, FDA-registered analytical testing laboratory, built specifically around foreign particulate matter investigation. But in practice, this means we don't just tell you what a particle is when it appears where it shouldn't. We tell you where it came from, how it got there, and what to do about it.
Our scientists apply an industrial forensics approach—combining advanced microscopy, spectroscopy, and materials characterization to isolate, identify, and trace contaminants back to their source. Whether the issue is a single complaint sample or a systemic manufacturing problem, the goal is the same: a clear, defensible answer that supports corrective action and satisfies regulatory scrutiny.

How We Support Our Clients
In-Depth Particle Analysis
Our expert use of Scanning Electron Microscopy (SEM) and Energy-Dispersive X-Ray Spectroscopy provides direct insights into particle morphology, essential to meet performance requirements.
Foreign Particulate Matter Analysis
Identifying and characterizing unwanted particles in pharmaceutical products to ensure patient safety and product integrity.
Particle Size and Distribution
Critical for understanding the behavior of active pharmaceutical ingredients (APIs) and excipients, impacting both manufacturing processes and product performance.
Contamination Identification
Utilizing state-of-the-art instrumentation to pinpoint sources of contamination that could compromise product quality.
Root Cause Analysis
Determining the origin of particulate contamination to enable corrective action.
Regulatory Support
Providing necessary laboratory analysis to navigate regulatory requirements for market approval.


Our Approach
At RJ Lee Group, our approach to the pharmaceutical industry is deeply rooted in our commitment to advancing public health through scientific excellence. We provide comprehensive analytical services, ensuring that our pharmaceutical partners meet the highest standards of product safety, efficacy, and quality.

Key Services
- Analytical Method Development
- Quality Control and Assurance
- Regulatory Compliance Support
- Environmental Monitoring
- Product Development Consulting
What Sets Us Apart
What distinguishes RJ Lee Group in the pharmaceutical sector is our ISO-compliant, FDA-registered laboratory capabilities, combined with a relentless pursuit of innovation in analytical methodologies. Our ability to navigate the complex regulatory landscape while maintaining a focus on scientific advancement positions us as a leader in pharmaceutical analysis.
Technologies
High-Performance Liquid Chromatography (HPLC) for compound analysis.
Mass Spectrometry for molecular structure determination
Clinical Data Management Systems for trial efficiency
Stability Chambers for drug shelf-life testing
Bioinformatics for innovative drug development
Representative Clients
Pharmaceutical Manufacturers
Biotechnology Firms
Research Institutions
Client Success Stories
Root‑cause analysis of foreign particulate contamination in a sterile pharmaceutical product using advanced microscopy and materials characterization, supporting corrective actions across manufacturing, filling, and packaging operations.
Discuss Pharmaceutical Consulting Services with an Expert

